Literature DB >> 21881204

Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.

Amaya I Wolf1, Krystyna Mozdzanowska, William J Quinn, Michele Metzgar, Katie L Williams, Andrew J Caton, Eric Meffre, Richard J Bram, Loren D Erickson, David Allman, Michael P Cancro, Jan Erikson.   

Abstract

Antiviral Abs, for example those produced in response to influenza virus infection, are critical for virus neutralization and defense against secondary infection. While the half-life of Abs is short, Ab titers can last a lifetime due to a subset of the Ab-secreting cells (ASCs) that is long lived. However, the mechanisms governing ASC longevity are poorly understood. Here, we have identified a critical role for extrinsic cytokine signals in the survival of respiratory tract ASCs in a mouse model of influenza infection. Irradiation of mice at various time points after influenza virus infection markedly diminished numbers of lung ASCs, suggesting that they are short-lived and require extrinsic factors in order to persist. Neutralization of the TNF superfamily cytokines B lymphocyte stimulator (BLyS; also known as BAFF) and a proliferation-inducing ligand (APRIL) reduced numbers of antiviral ASCs in the lungs and bone marrow, whereas ASCs in the spleen and lung-draining lymph node were surprisingly unaffected. Mice deficient in transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI), a receptor for BLyS and APRIL, mounted an initial antiviral B cell response similar to that generated in WT mice but failed to sustain protective Ab titers in the airways and serum, leading to increased susceptibility to secondary viral challenge. These studies highlight the importance of TACI signaling for the maintenance of ASCs and protection against influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881204      PMCID: PMC3195469          DOI: 10.1172/JCI57362

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  80 in total

1.  Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature.

Authors:  Elodie Mohr; Karine Serre; Rudolf A Manz; Adam F Cunningham; Mahmood Khan; Deborah L Hardie; Roger Bird; Ian C M MacLennan
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

2.  BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.

Authors:  Jean L Scholz; Jenni E Crowley; Mary M Tomayko; Natalie Steinel; Patrick J O'Neill; William J Quinn; Radhika Goenka; Juli P Miller; Yun Hee Cho; Vatana Long; Chris Ward; Thi-Sau Migone; Mark J Shlomchik; Michael P Cancro
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

3.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

4.  Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance.

Authors:  K Mozdzanowska; K Maiese; W Gerhard
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.

Authors:  Esra Ozcan; Lilit Garibyan; John Jhe-Yun Lee; Richard J Bram; Kong-Peng Lam; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2009-05-08       Impact factor: 10.793

6.  Plasmacytoid dendritic cells are dispensable during primary influenza virus infection.

Authors:  Amaya I Wolf; Darya Buehler; Scott E Hensley; Lois L Cavanagh; E John Wherry; Philippe Kastner; Susan Chan; Wolfgang Weninger
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

7.  Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.

Authors:  Jason E Stadanlick; Mary Kaileh; Fredrick G Karnell; Jean L Scholz; Juli P Miller; William J Quinn; Randall J Brezski; Laura S Treml; Kimberly A Jordan; John G Monroe; Ranjan Sen; Michael P Cancro
Journal:  Nat Immunol       Date:  2008-11-02       Impact factor: 25.606

8.  TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Authors:  X Z Xia; J Treanor; G Senaldi; S D Khare; T Boone; M Kelley; L E Theill; A Colombero; I Solovyev; F Lee; S McCabe; R Elliott; K Miner; N Hawkins; J Guo; M Stolina; G Yu; J Wang; J Delaney; S Y Meng; W J Boyle; H Hsu
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

9.  Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.

Authors:  Ulrich Salzer; Chiara Bacchelli; Sylvie Buckridge; Qiang Pan-Hammarström; Stephanie Jennings; Vassilis Lougaris; Astrid Bergbreiter; Tina Hagena; Jennifer Birmelin; Alessandro Plebani; A David B Webster; Hans-Hartmut Peter; Daniel Suez; Helen Chapel; Andrew McLean-Tooke; Gavin P Spickett; Stephanie Anover-Sombke; Hans D Ochs; Simon Urschel; Bernd H Belohradsky; Sanja Ugrinovic; Dinakantha S Kumararatne; Tatiana C Lawrence; Are M Holm; Jose L Franco; Ilka Schulze; Pascal Schneider; E Michael Gertz; Alejandro A Schäffer; Lennart Hammarström; Adrian J Thrasher; H Bobby Gaspar; Bodo Grimbacher
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

10.  The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells.

Authors:  Oliver Dienz; Sheri M Eaton; Jeffrey P Bond; Wendy Neveu; David Moquin; Rajkumar Noubade; Eva M Briso; Colette Charland; Warren J Leonard; Gennaro Ciliberto; Cory Teuscher; Laura Haynes; Mercedes Rincon
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  37 in total

1.  Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Samantha Meuwissen; Joseph R Plummer; James P McGettigan
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Fas/FasL and perforin-granzyme pathways mediated T cell cytotoxic responses in infectious bursal disease virus infected chickens.

Authors:  Abdul Rauf; Mahesh Khatri; Maria V Murgia; Yehia M Saif
Journal:  Results Immunol       Date:  2012-05-16

3.  TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.

Authors:  Windy R Allman; Ranadhir Dey; Lunhua Liu; Shafiuddin Siddiqui; Adam S Coleman; Parna Bhattacharya; Masahide Yano; Kadriye Uslu; Kazuyo Takeda; Hira L Nakhasi; Mustafa Akkoyunlu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 4.  Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche.

Authors:  Joel R Wilmore; David Allman
Journal:  J Immunol       Date:  2017-08-01       Impact factor: 5.422

5.  Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.

Authors:  Patrick Hanley; Jennifer A Sutter; Noah G Goodman; Yangzhu Du; Debora R Sekiguchi; Wenzhao Meng; Michael R Rickels; Ali Naji; Eline T Luning Prak
Journal:  Clin Immunol       Date:  2017-09-23       Impact factor: 3.969

6.  Immune Cell Dynamics in Rhesus Macaques Infected with a Brazilian Strain of Zika Virus.

Authors:  Eduardo L V Silveira; Kenneth A Rogers; Sanjeev Gumber; Praveen Amancha; Peng Xiao; Shawna M Woollard; Siddappa N Byrareddy; Mauro Martins Teixeira; Francois Villinger
Journal:  J Immunol       Date:  2017-06-30       Impact factor: 5.422

7.  Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease.

Authors:  Amaya I Wolf; Maura C Strauman; Krystyna Mozdzanowska; Katie L Williams; Lisa C Osborne; Hao Shen; Qin Liu; David Garlick; David Artis; Scott E Hensley; Andrew J Caton; Jeffrey N Weiser; Jan Erikson
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

8.  DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.

Authors:  Sachin Gupta; Emily S Clark; James M Termini; Justin Boucher; Saravana Kanagavelu; Celia C LeBranche; Sakhi Abraham; David C Montefiori; Wasif N Khan; Geoffrey W Stone
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

9.  TBK1 suppression of IgA in the NIK of time.

Authors:  Richard J Bram
Journal:  Nat Immunol       Date:  2012-11       Impact factor: 25.606

Review 10.  The Role of BAFF System Molecules in Host Response to Pathogens.

Authors:  Jiro Sakai; Mustafa Akkoyunlu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.